Page last updated: 2024-08-26

arginyl-glycyl-aspartic acid and Cancer of Nasopharynx

arginyl-glycyl-aspartic acid has been researched along with Cancer of Nasopharynx in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, J; Sheng, W; Wang, Y; Xie, Y; Yang, J1

Other Studies

1 other study(ies) available for arginyl-glycyl-aspartic acid and Cancer of Nasopharynx

ArticleYear
Adenovirus-mediated ING4/PTEN double tumor suppressor gene co-transfer modified by RGD enhances antitumor activity in human nasopharyngeal carcinoma cells.
    International journal of oncology, 2015, Volume: 46, Issue:3

    Topics: Adenoviridae; Animals; Carcinoma; Cell Cycle Proteins; Cells, Cultured; Gene Transfer Techniques; Genes, Tumor Suppressor; Genetic Therapy; Genetic Vectors; Homeodomain Proteins; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Oligopeptides; PTEN Phosphohydrolase; Transgenes; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays

2015